Table 5 Patient feedback on trial assessments
6 weeks (9 patients) | 3 months (9 patients) | |||||
|---|---|---|---|---|---|---|
Relevant | Nor relevant, nor irrelevant | Irrelevant | Relevant | Nor relevant, nor irrelevant | Irrelevant | |
6MWT | 88.9 % | 11.1 % | 0.0 % | 88.9 % | 0.0 % | 11.1 % |
10MWT | 66.7 % | 22.2 % | 1.1 % | 88.9 % | 0.0 % | 11.1 % |
EDX | 88.9 % | 11.1 % | 0.0 % | 100 % | 0.0 % | 0.0 % |
QOL | 55.6 % | 44.4 % | 0.0 % | 55.6 % | 33.3 % | 11.1 % |
WPAI | 66.7 % | 33.3 % | 0.0 % | 66.7 % | 11.1 % | 22.2 % |
Dynamometry | 88.9 % | 11.1 % | 0.0 % | 77.8 % | 11.1 % | 11.1 % |